Isabell Remus

Global Head Biosimilars @Sandoz

Munich, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2025 — Present

Global Head Biosimilars @Sandoz

View department →

Leading the Global Biosimilar business of Sandoz with the aim to further expand our pipeline, expand our market leadership and patient reach.

EDUCATION

1991 — 1993

ROBART Advertising GmbH

Werbekauffrau

1993 — 1997

ESB Business School, Reutlingen University

Dipl. Betriebswirt (FH); B.A. (Hons.) European Business Administration, Europäische Betriebswirtschaftslehre

ABOUT ISABELL REMUS

As the Global Head of Biosimilars, I lead Sandoz\'s efforts to further expand biosimilar market leadership, support our pipeline expansion, and increase access to essential biosimilar medicines. I joined Sandoz more than 15 years ago and have been working ever since to pioneer access to affordable, high-quality medicines, particularly biosimilars - which are critical to increasing patient access and maintaining sustainable healthcare systems.In addition to my executive responsibilities, I Chair the Biosimilar Medicines sector group at Medicines for Europe, collaborating with industry leaders and stakeholders to advocate for affordable, sustainable healthcare solutions.I have been working in the pharmaceutical industry for more than two decades, and in that time have taken a leading role in building and managing cross-functional teams, launching therapies across multiple indications, and shaping local, regional and global strategies. In my current role, I now have the opportunity to make a meaningful impact on global health and shaping the environments where science, strategy and patient needs intersect.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Isabell Remus — Global Head Biosimilars at Sandoz in Munich, DE | Unifers